Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

The Journal of Pediatrics

Volumn 121, Issue 1, 1992, Pages 138-141

  Galabert, C ^a,b,c   Montet, J C ^a,b,c   Lengrand, D ^a,b,c   Lecuire, A ^a,b,c   Sotta, C ^a,b,c   Figarella, C ^a,b,c   Chazalette, J P ^a,b,c  

^a HOSPICES CIVILS DE LYON   (France)

^b INSERM   (France)

^c CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTASIS; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG EFFECT; FEMALE; HUMAN; LIVER FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD;

5'-NUCLEOTIDASE; ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILE ACIDS AND SALTS; BILIRUBIN; CHILD; CHOLESTASIS; CHRONIC DISEASE; CYSTIC FIBROSIS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMAN; LIVER; MALE; SUPPORT, NON-U.S. GOV'T; URSODEOXYCHOLIC ACID;

EID: 0026718322     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)82561-2     Document Type: Article

References (11)

1. Hepatobiliary pathology in patients with cystic fibrosis
2. Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis
3. Serum bile acid composition in patients with cystic fibrosis
4. Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursode-oxycholate and their glycine and taurine conjugates
5. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport
6. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes
7. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts
8. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis
9. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and long-standing cholestasis
10. Improved electrophoretic resolution of bone and liver alkaline phosphatase resulting from partial digestion with neuraminidase
11. Les stéatorrhées infantiles. Leur caractérisation